POTENTIALLY MALIGNANT DISORDERS OF THE ORAL CAVITY – CLINICAL FEATURES

NATO KORSANTIA; ALEXANDER KATSITADZE; NINO ADAMASHVILI; NINO TSISKARISHVILI; NATALIA KILADZE; MANANA TEVZADZE; NINO KORSANTIA; LELA BERIDZE; TEA KATSITADZE

doi:10.52340/jecm.2022.03.13

POTENTIALLY MALIGNANT DISORDERS OF THE ORAL CAVITY – CLINICAL FEATURES

Authors

NATO KORSANTIA
ALEXANDER KATSITADZE
NINO ADAMASHVILI
NINO TSISKARISHVILI
NATALIA KILADZE
MANANA TEVZADZE
NINO KORSANTIA
LELA BERIDZE
TEA KATSITADZE

DOI:

https://doi.org/10.52340/jecm.2022.03.13

Keywords:

oral cavity, malignant, leukoplakia, erythroplakia, lichen planus

Abstract

Cancers of the oral cavity represent a significant worldwide health problem. Despite the general accessibility of the oral cavity during physical examination, many malignancies are not diagnosed until late stages of disease. A wide array of conditions has been implicated in the development of oral cancer, including leukoplakia, erythroplakia, palatal lesion of reverse cigar smoking, oral lichen planus, oral submucous fibrosis, discoid lupus erythematosus, and hereditary disorders such as dyskeratosis congenital and epidermolysis bullosa.In order to prevent malignant transformation of these precursor lesions, multiple screening and detection techniques have been developed to address this problem. The early detection of cancer is of critical importance because survival rates markedly improve when the oral lesion is identified at an early stage.

Downloads

Download data is not yet available.

References

Arlen D Meyers, LannyGarth Close – premalignant conditions of the oral cavity – article 1491418. emedicine. medscape, 2018.

Brad W.Neville, Terry A. Day – oral cancer and precancerous lesions. A cancer journal for clinicians. 2002.vol 52, issue 4, pp 195-215

Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007 Nov. 36(10):575-80.

Yardimci G, Kutlubay Z, Engin B, Tuzun Y. Precancerous lesions of oral mucosa. World J Clin Cases 2014;2:866-72

Steele TO, Meyers A. Early detection of premalignant lesions and oral cancer. Otolaryngol Clin North Am. 2011;44:221–229

Neville BW, Damm DD, Allen CM, et al. Oral & maxillofacial pathology. 2nd ed. Philadelphia, PA: Saunders; 2002. 337-369

Andre K, Schraub S, Mercier M, et al. Role of alcohol and tobacco in the aetiology of head and neck cancer: a case-control study in the Doubs region of France. Eur J Cancer B Oral Oncol. 1995 Sep. 31B(5):301-9

Schwimmer E. Die idiopathischen Schleim-hautplaques der Mundhöhle (Leukoplakia buccalis). Arch Dermat Syph 1877; 9: 570– 611.

Kramer IR, Lucas RB, Pindborg JJ, et al. WHO Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 518– 539.

Waldron CA, Shafer WG. Leukoplakia revisited: A clinicopathologic study of 3256 oral leukoplakias. Cancer 1975; 36: 1386– 1392

Greer RO. Pathology of malignant and premalignant oral epithelial lesions. Otolaryngol Clin North Am. 2006;39:249–275,

van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol. 2010;46:423–425.

Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–580.

Chen YW, Lin JS, Fong JH, Wang IK, Chou SJ, Wu CH, Lui MT, Chang CS, Kao SY. Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions. Br J Oral Maxillofac Surg.2007;45:590–591

Kawczyk-Krupka A, Waśkowska J, Raczkowska-Siostrzonek A, Kościarz-Grzesiok A, Kwiatek S, Straszak D, Latos W, Koszowski R, Sieroń A. Comparison of cryotherapy and photodynamic therapy in treatment of oral leukoplakia. Photodiagnosis Photodyn Ther. 2012;9:148–155.

Pietruska M, Sobaniec S, Bernaczyk P, Cholewa M, Pietruski JK, Dolińska E, Skurska A, Duraj E, Tokajuk G. Clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia. Photodiagnosis Photodyn Ther. 2014;11:34–40.

Queyrat L. Erythroplasie de gland. Bull Soc Franc Derm Syph 1911; 22: 378– 382

Kramer IR, Lucas RB, Pindborg JJ, et al. WHO Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 518– 539

Reichart PA, Philipsen HP. Oral erythroplakia--a review. Oral Oncol. 2005;41:551–561.

Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol. 2010;28:100–108.

Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci. 2007;49:89–106.

Canto AM, Müller H, Freitas RR, Santos PS. Oral lichen planus (OLP): clinical and complementary diagnosis. An Bras Dermatol. 2010;85:669–675.

Payeras MR, Cherubini K, Figueiredo MA, Salum FG. Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol. 2013;58:1057–1069

Martins-Filho PR, Da Silva LC, Piva MR. The prevalence of actinic cheilitis in farmers in a semi-arid northeastern region of Brazil. Int J Dermatol. 2011;50:1109–1114

Vieira RA, Minicucci EM, Marques ME, Marques SA. Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects. An Bras Dermatol. 2012;87:105–114

Santana Sarmento DJ, da Costa Miguel MC, Queiroz LM, Godoy GP, da Silveira EJ. Actinic cheilitis: clinicopathologic profile and association with degree of dysplasia. Int J Dermatol. 2014;53:466–472

ნატო კორსანტია, ა.კაციტაძე, ნ.ცისკარიშვილი, ნ.ადამაშვილი, ნინო კორსანტია, მ.შანიძე - ორალური წითელი ბრტყელი ლიქენის პათოგენეზის, დიფერენციალური დიაგნოზისა და მკურნალობის თანამედროვე ასპექტები. "Experimental and Clinical Medicine”. Tbilisi,2020,5,79-85

van der Waal I. Oral leukoplakia, the ongoing discussion on definition and terminology. Med Oral Patol Oral Cir Bucal. 2015;20(6):e685-e692.

van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal. 2014;19(4):e386-e390.

Lodi G, Franchini R, Warnakulasuriya S, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016;7:CD001829.

Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46(2): 207-214.

Mignogna MD, Lo Muzio L, Lo Russo L, et al. Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience. Oral Oncol. 2001;37(3):262-267.

Syrjanen S, Lodi G, von Bultzingslowen I, et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011;17 Suppl 1:58-72.

Ingafou M, Leao JC, Porter SR, et al. Oral lichen planus: a retrospective study of 690 British patients. Oral Dis. 2006;12(5):463-468.

Werner RN, Stockfleth E, Connolly SM, et al. Evidence- and consensus-based (S3) guidelines for the treatment of actinic keratosis—International League of Dermatological Societies in cooperation with the European Dermatology Forum— short version. J Eur Acad Dermatol Venereol. 2015;29(11):2069-2079.